Cargando…

Tumor-associated macrophages, potential targets for cancer treatment

The fact that various immune cells, including macrophages, can be found in tumor tissues has long been known. With the introduction of concept that macrophages differentiate into a classically or alternatively activated phenotype, the role of tumor-associated macrophages (TAMs) is now beginning to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Li, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549387/
https://www.ncbi.nlm.nih.gov/pubmed/28804638
http://dx.doi.org/10.1186/s40364-017-0106-7
_version_ 1783255969076084736
author Yang, Li
Zhang, Yi
author_facet Yang, Li
Zhang, Yi
author_sort Yang, Li
collection PubMed
description The fact that various immune cells, including macrophages, can be found in tumor tissues has long been known. With the introduction of concept that macrophages differentiate into a classically or alternatively activated phenotype, the role of tumor-associated macrophages (TAMs) is now beginning to be elucidated. TAMs act as “protumoral macrophages”, contributing to disease progression. As the relationship between TAMs and malignant tumors becomes clearer, TAMs are beginning to be seen as potential therapeutic targets in these cases. In this review, we will discuss how TAMs can be used as therapeutic targets of cancer in clinics.
format Online
Article
Text
id pubmed-5549387
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55493872017-08-11 Tumor-associated macrophages, potential targets for cancer treatment Yang, Li Zhang, Yi Biomark Res Review The fact that various immune cells, including macrophages, can be found in tumor tissues has long been known. With the introduction of concept that macrophages differentiate into a classically or alternatively activated phenotype, the role of tumor-associated macrophages (TAMs) is now beginning to be elucidated. TAMs act as “protumoral macrophages”, contributing to disease progression. As the relationship between TAMs and malignant tumors becomes clearer, TAMs are beginning to be seen as potential therapeutic targets in these cases. In this review, we will discuss how TAMs can be used as therapeutic targets of cancer in clinics. BioMed Central 2017-08-08 /pmc/articles/PMC5549387/ /pubmed/28804638 http://dx.doi.org/10.1186/s40364-017-0106-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Yang, Li
Zhang, Yi
Tumor-associated macrophages, potential targets for cancer treatment
title Tumor-associated macrophages, potential targets for cancer treatment
title_full Tumor-associated macrophages, potential targets for cancer treatment
title_fullStr Tumor-associated macrophages, potential targets for cancer treatment
title_full_unstemmed Tumor-associated macrophages, potential targets for cancer treatment
title_short Tumor-associated macrophages, potential targets for cancer treatment
title_sort tumor-associated macrophages, potential targets for cancer treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549387/
https://www.ncbi.nlm.nih.gov/pubmed/28804638
http://dx.doi.org/10.1186/s40364-017-0106-7
work_keys_str_mv AT yangli tumorassociatedmacrophagespotentialtargetsforcancertreatment
AT zhangyi tumorassociatedmacrophagespotentialtargetsforcancertreatment